Research Projects
BioMed Publications
2005-2010
Indwelling urinary catheters are used to manage
bladder drainage in patients with voiding difficulties or incontinence. They
are often considered a ‘last resort’ due to the complications that can
arise. One of these is blockage, which
can happen without warning. The BioMed
and the University of the West of England,
Our first challenge is to develop bioluminescent forms
of the type of bacteria which commonly infect urinary
catheters. Once this has been achieved we
Patients who rely on an indwelling catheter for draining the bladder often use a drainage bag into which the urine collects. Common practice dictates that the bag is replaced every 5-7 days while the catheter itself may be replaced between 28 and 90 days, depending on the type of catheter. If a patient suffers from a Proteus mirabilis infection, the catheter may be replaced more frequently due to blockage caused by a mineral biofilm.
Although the use of a closed
drainage system is now standard practice, infection can still occur via the intraluminal route. If the drainage tube is disconnected from the catheter bacteria have a
chance to enter into the internal lumen and infect. Contamination of the tap of the drainage bag
can occur during regular opening to drain urine. Damage of a drainage bag can allow bacteria
to enter the closed system as well. If
we can maintain a sterile environment within the drainage bag, we can reduce
the risk of infection.
This study set out to determine whether a novel disinfectant
was active against a range of urinary tract pathogens and could therefore be
used to maintain a sterile environment within the drainage bag. ECAS (ElectroChemically-Activated
Solution) is generated from low halide salt solutions via specially designed
electrolytic cells. The use of ECAS has
been exploited widely outside of
Sets of in vitro bladder models were infected with a high bacterial population and ~80ml of ECAS
was put into the drainage bag. Over a period
of 8 hours the ECAS was able to decontaminate the urine in the bag thus
reducing the risk of infection via the intraluminal route. ECAS was very active against Pr. mirabilis, Ps. aeruginosa, K. pneumoniae, Ent. faecalis and E. coli, with weak solutions
(between 1-2%) killing all bacteria in lab tests. It was found that the efficacy of ECAS was
inhibited by organic load. This was
overcome by using more of the disinfectant to counter any inhibition. The activity of ECAS also reduces over
time. This allows for disposal of excess
solution without the risk of adverse environmental consequences.
This study has demonstrated that ECAS is an effective
disinfectant at low concentrations and could have beneficial patient outcomes
especially in hospital or nursing home settings, preventing cross contamination
of the drainage system. We would like
to see if this approach could reduce the rate of infections in a clinical
setting.
This study was funded by North Bristol NHS Trust in
collaboration with the University of the West of England.
This
prospective study looked at a group of long-term catheter users infected with
Proteus bacteria, the most common causer of catheter encrustation. It
investigated how much the rate of catheter blockage varies between patients,
what the reasons for this might be, and if it might be possible to have Proteus
infection but not catheter blockage. Proteus organisms colonise the catheter surfaces, forming biofilm communities embedded in an adhesive
polysaccharide matrix. The enzyme urease produced by
the bacteria hydrolyses urea, an end-product present in urine, to form ammonia
which raises the pH of the urine. Normally the voiding pH of urine (pH v) is
below its nucleation pH (pH n), the pH at which calcium and magnesium salts
precipitate out of solution. A clear margin between the two values is usually
present. However when Proteus mirabilis infects the urinary tract, its urease activity can elevate the voiding pH above the nucleation
pH so that crystals of magnesium ammonium phosphate (struvite)
and calcium phosphate (hydroxyapatite) form inside
the catheter and become trapped in the biofilm. The continued development of
these encrustations eventually blocks the catheter lumen. All types of catheter
currently available are vulnerable to blockage by crystalline P. mirabilis biofilms.
It
is known that catheter blockers tend to have a higher pH than non-blockers. We
found that people whose catheters took longer to block tended to have a higher
nucleation pH than the rapid blockers, but there was no difference in voided
urine pH. It appears that nucleation pH is not fixed for an individual and so
could possibly be manipulated with treatment to slow down the encrustation
process.
Stickler DJ, Morgan SD. Modulation of crystalline Proteus mirabilis biofilm development on urinary catheters. J Med Microbiol 2006 May; 55 (Pt 5): 489-94
Sabbuba NA et al. Does the valve regulated release of urine from the bladder decrease encrustation and blockage of indwelling catheters by crystalline Proteusmirabilis biofilms? The Journal of Urology 2005; 173 (262-266)
To empty the bladder, patients can either use a catheter bag or a valve. With a catheter bag, urine is allowed to drain continuously into the bag, rather than the bladder filling and emptying naturally. When a valve is attached to the end of the catheter, the bladder can fill when the valve is closed and be emptied when the valve is opened at a convenient time and place for the user. Continual drainage creates an abnormal state for the bladder due to the loss of the natural filling and emptying cycle, and the study will investigate whether there are any differences in the degree of inflammation between patients who use catheter bags and those who use catheter valves.
The BUI are collaborating with the Continence Technology and Skin Health Group at the University of Southampton , who are leading the project. The BUI commenced the study in May 2009 and are asking patients who have a catheter to participate in a single one hour visit. Recruitment will last for up to 6 months.
^ back to the top